Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Irritable Bowel Syndrome

  Free Subscription


2 Aliment Pharmacol Ther
1 Am J Cardiol
1 Am J Gastroenterol
1 BMC Gastroenterol
2 Clin Gastroenterol Hepatol
1 Crit Rev Anal Chem
1 Gastroenterol Clin North Am
1 Gastroenterol Hepatol
1 Infect Immun
1 J Clin Gastroenterol
1 J Pharmacol Sci
1 Medicine (Baltimore)
2 Microb Pathog
1 Minerva Gastroenterol (Torino)
1 PeerJ
1 Saudi J Gastroenterol
1 World J Gastroenterol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Aliment Pharmacol Ther

  1. BLACK CJ, Ford AC
    Editorial: co-morbid gastrointestinal conditions are an important consideration in IBS management-authors' reply.
    Aliment Pharmacol Ther. 2021;53:1153-1154.

  2. SIMONS M, Taft TH
    Editorial: co-morbid gastrointestinal conditions are an important consideration in IBS management.
    Aliment Pharmacol Ther. 2021;53:1151-1152.

    Am J Cardiol

  3. SARICA AS, Bor S, Orman MN, Barajas-Martinez H, et al
    Frequency of Irritable Bowel Syndrome in Patients with Brugada Syndrome and Drug-Induced Type 1 Brugada Pattern.
    Am J Cardiol. 2021 May 22. pii: S0002-9149(21)00363.
    PubMed         Abstract available

    Am J Gastroenterol

  4. SHAH ED, Lacy BE, Chey WD, Chang L, et al
    Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials.
    Am J Gastroenterol. 2021 May 25. pii: 00000434-900000000-98765.
    PubMed         Abstract available

    BMC Gastroenterol

  5. PROSPERO L, Riezzo G, Linsalata M, Orlando A, et al
    Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity.
    BMC Gastroenterol. 2021;21:235.
    PubMed         Abstract available

    Clin Gastroenterol Hepatol

  6. LENHART A, Dong T, Joshi S, Jaffe N, et al
    Effect of Exclusion Diets on Symptom Severity and the Gut Microbiota in Patients with Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2021 May 19. pii: S1542-3565(21)00565.
    PubMed         Abstract available

  7. LACY BE, Brenner DM, Chey WD
    Reevaluation of the Cardiovascular Safety Profile of Tegaserod: A Review of the Clinical Data.
    Clin Gastroenterol Hepatol. 2021 May 25. pii: S1542-3565(21)00578.
    PubMed         Abstract available

    Crit Rev Anal Chem

  8. SHRIVASTAVA A, Mittal A
    A Mini Review on Characteristics and Analytical Methods of Otilonium Bromide.
    Crit Rev Anal Chem. 2021 May 26:1-9. doi: 10.1080/10408347.2021.1913983.
    PubMed         Abstract available

    Gastroenterol Clin North Am

  9. BERUMEN A, Edwinson AL, Grover M
    Post-infection Irritable Bowel Syndrome.
    Gastroenterol Clin North Am. 2021;50:445-461.
    PubMed         Abstract available

    Gastroenterol Hepatol

  10. PEREZ DE ARCE E, Quera R, Beltran CJ, Madrid AM, et al
    Irritable Bowel Syndrome in Inflammatory Bowel Disease. Synergy in alterations of the gut-brain axis?
    Gastroenterol Hepatol. 2021 May 20. pii: S0210-5705(21)00143.
    PubMed         Abstract available

    Infect Immun

  11. CALLAHAN SM, Dolislager CG, Johnson JG
    The host cellular immune response to infection by Campylobacter spp. and its role in disease.
    Infect Immun. 2021 May 24. pii: IAI.00116-21. doi: 10.1128/IAI.00116.
    PubMed         Abstract available

    J Clin Gastroenterol

  12. SAHA S, Sehgal K, Singh S, Grover M, et al
    Postinfection Irritable Bowel Syndrome Following Clostridioides difficile Infection: A Systematic-review and Meta-analysis.
    J Clin Gastroenterol. 2021 May 28. pii: 00004836-900000000-97410.
    PubMed         Abstract available

    J Pharmacol Sci

  13. NOZU T, Miyagishi S, Nozu R, Ishioh M, et al
    EMA401, an angiotensin II type 2 receptor antagonist blocks visceral hypersensitivity and colonic hyperpermeability in rat model of irritable bowel syndrome.
    J Pharmacol Sci. 2021;146:121-124.
    PubMed         Abstract available

    Medicine (Baltimore)

  14. LI J, Wang C, Li ZM, Fu B, et al
    Abnormalities of intrinsic brain activity in irritable bowel syndrome (IBS): A protocol for systematic review and meta analysis of resting-state functional imaging.
    Medicine (Baltimore). 2021;100:e25883.
    PubMed         Abstract available

    Microb Pathog

  15. LI DH, Li ZP, Yan-Zhang, Zhou GZ, et al
    Fecal Fusobacterium nucleatum harbored virulence gene fadA are associated with ulcerative colitis and clinical outcomes.
    Microb Pathog. 2021 May 19:104964. doi: 10.1016/j.micpath.2021.104964.
    PubMed         Abstract available

  16. HOU JJ, Wang X, Li Y, Su S, et al
    The relationship between gut microbiota and proteolytic activity in irritable bowel syndrome.
    Microb Pathog. 2021 May 25:104995. doi: 10.1016/j.micpath.2021.104995.
    PubMed         Abstract available

    Minerva Gastroenterol (Torino)

  17. MARI A, Sbeit W, Pellicano R, Khoury T, et al
    The interplay between pancreatic enzymes insufficiency and irritable bowel syndrome.
    Minerva Gastroenterol (Torino). 2021;67:173-174.


  18. ROGERS AE, Hu YJ, Yue Y, Wissel EF, et al
    Shiftwork, functional bowel symptoms, and the microbiome.
    PeerJ. 2021;9:e11406.
    PubMed         Abstract available

    Saudi J Gastroenterol

    Antispasmodics in irritable bowel syndrome - a hoary old chestnut?
    Saudi J Gastroenterol. 2021 May 21. pii: 316603. doi: 10.4103.

    World J Gastroenterol

  20. EL-SALHY M, Casen C, Valeur J, Hausken T, et al
    Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome.
    World J Gastroenterol. 2021;27:2219-2237.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.